VARIZIG

Varicella Zoster Immune Globulin (Human)

Saol Therapeutics

VARIZIG is a Varicella Zoster Immune Globulin (Human) indicated for postexposure
prophylaxis in high risk individuals (1). High risk groups include:

• immunocompromised children and adults,
• newborns of mothers with varicella shortly before or after delivery,
• premature infants,
• infants less than one year of age,
• adults without evidence of immunity,
• pregnant women.

VARIZIG administration is intended to reduce the severity of varicella.

Store VARIZIG at 2 to 8°C (36 to 46°F). Do not freeze. Do not use after expiration date.